Search Results 1931-1940 of 13396 for monoclonal antibody

1. Clinical trials - Oncology (Medical)

   * Whether the body makes antibodies against the study drug(s) (which ... antibody) * Olaparib (a type of PARP inhibitor). Pagination Clinical studies.

2. Clinical trials - Oncology (Medical)

   ... antibody) * Olaparib (a type of PARP inhibitor). Mayo Clinic Cancer Center ... * Whether the body makes antibodies against the study drug(s) (which ...

3. A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 in Amyotrophic Lateral Sclerosis (ALS) Patients - Mayo Clinic

   Current hepatitis C infection (defined as positive hepatitis C virus [HCV] antibody and detectable HCV RNA). Participants with positive HCV antibody and ...

4. Mayo Clinic researchers present advances in immunotherapy, biomarkers and tumor biology at AACR 2026

   Description: The first study to demonstrate that a cancer vaccine can be delivered concurrently with an antibody-drug conjugate without increasing adverse ...

5. A Safety And Efficacy Study Of FCR001 Vs Standard Of Care In De Novo Living Donor Kidney Transplantation (FREEDOM-1) - Mayo Clinic

   Panel reactive antibodies (calculated panel reactive antibody > 20% by Flow/Luminex). ... Presence of donor-specific antibodies (DSA) at any time pre-transplant.

6. XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia - Mayo Clinic

   surface antibody) must have an undetectable hepatitis B viral load. Subjects who have positive hepatitis C antibody may be included if they have an ...

7. Mayo Clinic researchers identify therapy that shrinks tumors in patients with multiple myeloma

   Multiple myeloma is a blood cancer that affects plasma cells – white blood cells that normally produce antibodies to fight infection. Rather than produce ...

8. Interpreting the News: COVID-19 Experimental Vaccines

   What is the significance of the BNT162b2 vaccine reportedly causing both antibodies and T cells to be made by the host? The immune system has two arms: humoral ...

9. A Study To Evaluate Larotrectinib To Treat Patients With Previously Untreated TRK Fusion Solid Tumors And TRK Fusion Relapsed Acute Leukemia - Mayo Clinic

   Antibodies: ≥ 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to grade ≤ 1.

10. Publications - Craig M. Horbinski, M.D. - Mayo Clinic

    F3 Expression Drives Sensitivity to the Antibody-Drug Conjugate Tisotumab Vedotin in Glioblastoma. ... B cell-based therapy produces antibodies that ...